RGNX
REGENXBIO Inc.
REGENXBIO Inc. (RGNX) has 13 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 6, 2026.
The most active filer is Chief Medical Officer PAKOLA STEVE with 4 filings. Insiders have net sold $887K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Curran Simpson
- Employees:371
- HQ:Rockville, MD, US
- IPO:2015-09-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$887K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$523.2M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 2,161 | $29K | Jul 6 | SEC ↗ | |
| Chief Medical Officer | Sale | 19,608 | $216K | Jul 1 | SEC ↗ | |
| Chief Medical Officer | Sale | 36,725 | $472K | Jul 1 | SEC ↗ | |
PAKOLA STEVEFirst filing | Chief Medical Officer | Sale | 15,309 | $169K | May 13 | SEC ↗ |
Related companies
REGENXBIO Inc. is in the Healthcare sector.